Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
PlacementTracker Publishes 2017 PIPE and Private Placement Markets League Tables
-
Strongbridge Biopharma (SBBP) Buys U.S. and Canadian Rights to MACRILEN from Aeterna Zentaris (AEZS)
-
Strongbridge Biopharma plc Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna Zentaris
-
UPDATE: Cantor Fitzgerald Upgrades Luxoft Holding (LXFT) to Overweight Citing Improving Risk/Reward Profile
-
HTG Molecular Diagnostics (HTGM) Plans 10M Share Public Offering of Common Stock
-
Genocea Biosciences (GNCA) Announces Public Offerings of Common Stock, Class A Warrants, Series A Convertible Preferred Stock and Class A Warrants
-
HTG Molecular Diagnostics Announces Proposed Public Offering of Common Stock
-
Genocea Biosciences, Inc. Announces Proposed Concurrent Public Offerings of Common Stock and Class A Warrants and Series A Convertible Preferred Stock and Class A Warrants
-
UnitedHealth Group (UNH) PT Raised to $280 at Cantor Fitzgerald
-
Infosys Technologies (INFy) PT Raised to $16 at Cantor Fitzgerald
-
ProPhotonix to Exhibit at Photonics West 2018
-
Evolent Health (EVH) PT Lowered to $28 at Cantor Fitzgerald, Says Shares Remain Compelling
-
Orchid Island Capital Announces January 2018 Monthly Dividend and December 31, 2017 RMBS Portfolio Characteristics
-
Veteran Investors and Operating Executives Launch Hunter Street Partners
-
Cardiome to Participate in the Cantor Fitzgerald Antibiotics Summit
-
Cantor Fitzgerald Remains Bullish on Perrigo (PRGO) Following CEO Appointment
-
Cantor Fitzgerald Reiterates Overweight on Aclaris Therapeutics (ACRS)
-
Evolus, Inc. Files Registration Statement for Proposed Initial Public Offering
-
Cerus (CERS) Amends $70M ATM Offering Via Cantor Fitzgerald
-
Shire (SHPG) Neuroscience Decision Has Positive Read-through to Neos Therapeutics (NEOS) - Cantor
-
Envision Healthcare (EVHC) PT Raised to $37 at Cantor Fitzgerald Following Tax Reduction
-
Pre-Market Technical Scan on Biotech Equities -- Ignyta, Pluristem Therapeutics, Ritter Pharma, and Tenax Therapeutics
-
ProPhotonix awarded IDA grant for capital expansion program
-
Pre-Open Movers 01/05: (CNIT) (DWCH) (FC) Higher; (OHRP) (RGNX) (FRAN) Lower (more...)
-
After-Hours Stock Movers 01/04: (DWCH) (FC) (AMRN) Higher; (RGNX) (FRAN) (NOVN) Lower (more...)
-
Cantor Fitzgerald Assumes, Upgrades Intuitive Surgical (ISRG) to Overweight
-
Cantor Fitzgerald Assumes, Upgrades Zimmer Biomet (ZBH) to Overweight
-
Cantor Fitzgerald Assumes AxoGen, Inc. (AXGN) at Overweight
-
Cantor Fitzgerald Assumes Cerus (CERS) at Overweight
-
Cantor Fitzgerald Assumes Downgrades Integra LifeSciences (IART) to Neutral
-
Cantor Fitzgerald Assumes ViewRay Inc. (VRAY) at Overweight
-
Cantor Fitzgerald Assumes Stryker (SYK) at Neutral
-
Cantor Fitzgerald Assumes Wright Medical (WMGI) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Royal Gold (RGLD) at Overweight
-
Upstream Completes Transaction with Drayer Physical Therapy Institute
-
Optinose Announces $100 Million Debt Financing from Athyrium Capital Management
-
Optinose Announces $100 Million Debt Financing from Athyrium Capital Management
-
Energy Fuels Renews Its ATM Program
-
Cantor Fitzgerald Downgrades Ignyta, Inc (RXDX) to Neutral Following Acquisition
-
Horizon Pharma (HZNP) Expanded Procysbi Label Highlighting The Importance Of Treating Early - Cantor Fitzgerald
-
Glaukos Corporation (GKOS) PT Lowered to $48 at Cantor Fitzgerald
-
BGC Partners And Newmark Group Announce Exercise And Closing Of Overallotment Option For The Newmark Group Initial Public Offering
-
Valeant Pharmaceuticals (VRX) 2018 Outlook 'Keeps Getting Better' - Cantor Fitzgerald
-
Mallinckrodt's (MNK) Sucampo Acquisition 'Is A Smart Strategic Deal' - Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight on UnitedHealth Group (UNH) Following 8-K Filing
-
Agile Therapeutics (AGRX) PT Lowered to $5 at Cantor Fitzgerald
-
Accenture plc (ACN) PT Raised to $180 at Cantor Fitzgerald Following Strong 1Q
-
Cantor Fitzgerald Starts Tier Technologies (TIER) at Overweight, 'A Transformed Portfolio Positioned for Growth'
-
Form 4 NEWMARK GROUP, INC. For: Dec 13 Filed by: CANTOR FITZGERALD, L. P.
-
Form 4 BGC Partners, Inc. For: Dec 13 Filed by: CANTOR FITZGERALD, L. P.

